×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
四川大学 [13]
内容类型
期刊论文 [13]
发表日期
2019 [1]
2018 [6]
2017 [2]
2015 [1]
2014 [1]
2011 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共13条,第1-10条
帮助
限定条件
专题:四川大学
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells
期刊论文
Oncogene, 2019
作者:
Hongyu Zhou
;
Chunlei Yu
;
Lingmei Kong
;
Xiaoliang Xu
;
Juming Yan
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/02/25
Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase dual inhibitors for regulating breast cancer cells apoptosis and autophagy
期刊论文
European Journal of Medicinal Chemistry, 2018, 卷号: Vol.144, 页码: 517-528
作者:
Pan, Z.
;
Chen, Y.
;
Liu, J.
;
Jiang, Q.
;
Yang, S.
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/02/25
Apoptosis
Autophagy
Breast
cancer
EEF2K
Kinase
inhibitor
PLK1
Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors.
期刊论文
World journal of gastroenterology, 2018, 卷号: Vol.24 No.46, 页码: 5189-5202
作者:
Li Jian
;
Wang Ming
;
Zhang Bo
;
Wu Xin
;
Lin Tian-Long
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/02/25
China
Consensus
guideline
Gastrointestinal
stromal
tumor
Side
effects
Tyrosine
kinase
inhibitors
Co-delivery of aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy
期刊论文
International Journal of Nanomedicine, 2018, 卷号: Vol.13, 页码: 1443-1456
作者:
Duan, X.
;
Mu, M.
;
Yan, J.
;
Bai, L.
;
Zhong, L.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/02/25
Apoptosis
Aurora-A
kinase
inhibitor
Co-delivery
Liposome
Melanoma
RNA
interference
Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study.
期刊论文
Translational neurodegeneration, 2018, 页码: 32
作者:
Zhang Zhenxin
;
Wang Jian
;
Chen Shengdi
;
Liu Chunfeng
;
Zhang Baorong
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/02/25
China
Monoamine
oxidase
inhibitor
Monotherapy
Parkinson’s
disease
Rasagiline
Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors
期刊论文
World Journal of Gastroenterology, 2018, 卷号: 第46期, 页码: 5189-5202
作者:
Jian Li, Ming Wang, Bo Zhang, Xin Wu, Tian-Long Lin, Xiu-Feng Liu, Ye Zhou, Xin-Hua Zhang, Hao Xu,Li-Jing Shen, Jing Zou, Ping Lu, Dong Zhang, Wei-Jun Gu, Mei-Xia Zhang, Jian Pan, Hui Cao
;
Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/02/25
Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study.
期刊论文
Translational neurodegeneration, 2018, 页码: 32
作者:
Zhang Zhenxin
;
Wang Jian
;
Chen Shengdi
;
Liu Chunfeng
;
Zhang Baorong
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/02/25
China
Monoamine
oxidase
inhibitor
Monotherapy
Parkinson’s
disease
Rasagiline
Novel Ferulic Acid-donepezil Hybrids as Multifunctional Agents for th e Treatment of Alzheimer’s Disease with Butyrylcholinesterase, Amyloid- β, Antioxidant and Neuroprotective Properties
期刊论文
Letters in Drug Design & Discovery, 2017, 卷号: Vol.14 No.8, 页码: 918-929
作者:
Tianping Li
;
Wanli Pan
;
Keren Wang
;
Wenmin Liu
;
Qianwen Ma and Zhipei Sang
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/02/25
Alzheimer\'s disease
ferulic acid-donepezil hybrids
antioxidant activity
BuChE inhibitor
Aβ aggregation
neuroprotective effects
blood-brain barrier.
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
期刊论文
Journal of Hepatology, 2017, 卷号: Vol.67 No.6, 页码: 1194-1203
作者:
Zhang, S.
;
Song, X.
;
Cao, D.
;
Xu, Z.
;
Fan, B.
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/02/25
Dual
mTOR
inhibitor
Gemcitabine
Intrahepatic
cholangiocarcinoma
MLN0128
Mouse
model
Targeted
therapy
Translational
medicine
A preclinical evaluation of SKLB261, a multi-kinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
期刊论文
Molecular Cancer Therapeutics, 2015, 卷号: Vol.14 No.2, 页码: 407-418
作者:
Pan Y
;
Zheng M
;
Zhong L
;
Yang J
;
Zhou S
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/03/01
©版权所有 ©2017 CSpace - Powered by
CSpace